Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate no longer looking for participants. The page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading with an updated revision label to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T17:32:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, signaling a new build of the page. No visible content changes to the study details or layout are indicated by this update.
    Difference
    0.1%
    Check dated 2026-06-05T17:51:42.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.4, indicating a minor internal update to the study page. No visible content or feature changes are implied by this update.
    Difference
    0.1%
    Check dated 2026-05-15T05:46:51.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a newer ClinicalTrials.gov release revision number (v3.5.3 instead of v3.5.2) in the footer, indicating an update to the site’s versioning rather than the trial record details.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:40.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:48.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Added a Resources section linking to the Genetic and Rare Diseases Information Center for Squamous cell Carcinoma of the Head and Neck.
    Difference
    0.2%
    Check dated 2026-04-02T15:25:39.000Z thumbnail image

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.